Breaking News

Theorem Promotes Veteran Researcher

September 10, 2013

Lake to lead respiratory biopharma franchise

Phil Lake has been appointed executive director of biopharmaceutical development, respiratory, at Theorem Clinical Research. Mr. Lake will be responsible for senior oversight on major projects as well as building the company’s respiratory business globally.
 
Mr. Lake joined Theorem as senior director of project management in 2012. He has held positions including managing director of Springfield Clinical Consulting, executive director of project management in Europe for Covance and as senior clinical research manager for GlaxoSmithKline in London. He has significant therapeutic experience in respiratory disorders, including numerous COPD and asthma studies.
 
“Phil Lake has been a tremendous asset to our European operations, and I am confident he has the contacts and experience to take our biopharmaceuticals division to the next level,” said Theorem president and chief executive officer, John Potthoff.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important